Back to search
Rotavirus Gastroenteritis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rotavirus Gastroenteritis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rotavirus Gastroenteritis trials you may qualify forThe Phase II clinical trial of the oral hexavalent reassortant rotavirus attenuated live vaccine (Vero Cells) will be conducted in infants aged 6 to 12 weeks. T…
Background: China's healthcare system for children faces significant challenges, particularly due to the limited pediatric service capacity of primary healthcar…
The Phase I clinical trial of the oral hexavalent reassortant rotavirus attenuated live vaccine (Vero Cells) will be conducted in a population ranging from 6 we…
To determine the effectiveness of rotavirus vaccines, active surveillance will be conducted at two sites, Cincinnati Children's Hospital Medical Center (CCHMC)…
The aim of this study is to evaluate the effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastr…